Nutritional Supplements for Knee Surgery Recovery
Trial Summary
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are currently taking fish oils, steroids, or certain blood thinners. It's best to discuss your specific medications with the trial team.
What evidence supports the effectiveness of the treatment Omega-3 Fatty Acids and Essential Amino Acids for knee surgery recovery?
Is it safe to use omega-3 fatty acids and essential amino acids for surgery recovery?
Research suggests that omega-3 fatty acids are generally safe for use in humans, including surgical patients, and may even offer benefits like reduced inflammation and shorter hospital stays. Prescription formulations of omega-3 fatty acids have been tested in clinical trials and are considered safe at FDA-approved dosages.15678
How is the treatment of Omega-3 Fatty Acids and Essential Amino Acids for knee surgery recovery different from other treatments?
This treatment is unique because it uses Omega-3 fatty acids, which have anti-inflammatory and antioxidant effects, potentially reducing muscle weakness after knee surgery. Unlike other treatments, it focuses on improving recovery by modulating inflammation and oxidative stress, which are common after surgery.12579
What is the purpose of this trial?
Loss of skeletal muscle mass (atrophy) and strength in the lower limb are consequences of elective knee surgery as result of prolonged disuse from limb immobilization and impaired mobility, as well as pathophysiological trauma. The highest rates of skeletal muscle mass and strength loss occur during the 2-week post-surgery period, considered the early phase of outpatient recovery. Alternative to resistance exercise and pharmacology, nutritional intervention represents one strategy to combat skeletal muscle disuse atrophy.Essential amino acids (EAA) and omega-3 fatty acids are known to independently potentiate rates of skeletal muscle protein synthesis and attenuate skeletal muscle atrophy in humans. However, the combined actions these nutritional strategies on skeletal muscle have not been explored in a pathophysiological context, such as surgery. With the ultimate goal to test the efficacy of the combined nutritional strategy to attenuate skeletal muscle disuse atrophy in the future, the aim of this present pilot study is to explore the feasibility of recruitment and retention of anterior cruciate ligament reconstruction (ACLR) outpatients from a single centre across 18 months for a 6-week nutritional intervention. Participants will consume either an intervention of omega-3 fatty acids and EAAs, or a placebo control of safflower oil and non-essential amino acids (NEAA), for 4 weeks before and 2 weeks after elective ACLR surgery. Furthermore, this pilot will characterize secondary outcomes of skeletal muscle mass, strength, and power, and integrated rates of muscle protein synthesis, as well as report participant adherence to protocols and incidence of adverse events.
Research Team
Chris McGlory, PhD
Principal Investigator
Queen's University
Eligibility Criteria
This trial is for adults with a diagnosed anterior cruciate ligament injury who are scheduled for reconstruction surgery using patellar or quadriceps tendon grafts in Kingston, ON. It's designed to see if certain nutritional supplements can help prevent muscle loss after knee surgery.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pre-Surgery Nutritional Intervention
Participants receive omega-3 fatty acids and EAAs or placebo for 4 weeks before surgery
Post-Surgery Nutritional Intervention
Participants continue receiving omega-3 fatty acids and EAAs or placebo for 2 weeks after surgery
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Omega-3 Fatty Acids and Essential Amino Acids
Omega-3 Fatty Acids and Essential Amino Acids is already approved in United States, European Union for the following indications:
- Hypertriglyceridemia
- Cardiovascular health
- Hypertriglyceridemia
- Cardiovascular health
- Inflammation
- Nutritional supplement
- Muscle recovery
- Nutritional supplement
- Muscle recovery
- Wound healing
Find a Clinic Near You
Who Is Running the Clinical Trial?
Dr. Chris McGlory, PhD
Lead Sponsor
Dr. Chris McGlory, PhD
Lead Sponsor